XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING ACTIVITIES:    
Net (Loss) Income $ (3,281) $ 24,226
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 30,566 31,143
Non-cash impairment charges 7,064 0
Deferred income tax provision (benefit) (2,856) 1,953
Share-based compensation 5,599 3,620
Amortization of debt issuance costs and expenses associated with debt refinancing 1,398 1,890
Non-cash lease expense 149 1,260
Loss (gain) on disposal of property and equipment 12 (23)
Change in fair value of contingent consideration and others 456 4,699
Changes in assets and liabilities:    
Accounts receivable 16,827 10,041
Inventories (19,021) (25,423)
Prepaid expenses and other current assets (2,676) (2,164)
Other non-current assets 339 (6,009)
Accounts payable, accrued expenses and other current liabilities (19,210) (4,984)
Contract liabilities (1,498) 430
Other non-current liabilities 1,888 (14,503)
Net cash provided by operating activities 15,756 26,156
INVESTING ACTIVITIES:    
Purchases of property and equipment (15,465) (13,704)
Purchases of Investments (38,500) 0
Net cash used in investing activities (53,965) (13,704)
FINANCING ACTIVITIES:    
Proceeds from borrowings of long-term indebtedness 370,500 10,200
Payments on debt (15,100) (12,400)
Payment of debt issuance costs 0 (7,578)
Purchases of treasury stock 0 (150,000)
Proceeds from exercised stock options 6,398 2,326
Cash taxes paid in net equity settlement (3,122) (5,231)
Net cash provided by (used in) financing activities 358,676 (162,683)
Effect of exchange rate changes on cash and cash equivalents (4,963) 937
Net increase (decrease) in cash and cash equivalents 315,504 (149,294)
Cash and cash equivalents at beginning of period 276,402 456,661
Cash and cash equivalents at end of period $ 591,906 $ 307,367